["If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has t315i, one recommended therapy is ponatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is ponatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is asciminib.", "If a patient with Breast Cancer cancer has e17k, one recommended therapy is capivasertib,fulvestrant.", "If a patient with Melanoma cancer has v600e, one recommended therapy is dabrafenib.", "If a patient with All Solid Tumors cancer has v600e, one recommended therapy is dabrafenib,trametinib.", "If a patient with Anaplastic Thyroid Cancer cancer has v600e, one recommended therapy is dabrafenib,trametinib.", "If a patient with Hepatobiliary Cancer cancer has v600e, one recommended therapy is dabrafenib,trametinib.", "If a patient with Biliary Tract cancer has v600e, one recommended therapy is dabrafenib,trametinib.", "If a patient with Low-Grade Glioma, NOS cancer has v600e, one recommended therapy is dabrafenib,trametinib.", "If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is dabrafenib,trametinib.", "If a patient with Non-Small Cell Lung Cancer cancer has v600e, one recommended therapy is dabrafenib,trametinib.", "If a patient with Colorectal Cancer cancer has v600e, one recommended therapy is encorafenib,cetuximab.", "If a patient with Colorectal Cancer cancer has v600e, one recommended therapy is encorafenib,cetuximab,folfox regimen.", "If a patient with Low-Grade Glioma, NOS cancer has v600, one recommended therapy is tovorafenib.", "If a patient with Erdheim-Chester Disease cancer has v600, one recommended therapy is vemurafenib.", "If a patient with Melanoma cancer has v600, one recommended therapy is vemurafenib,atezolizumab,cobimetinib.", "If a patient with Non-Small Cell Lung Cancer cancer has v600e, one recommended therapy is encorafenib,binimetinib.", "If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is trametinib.", "If a patient with Melanoma cancer has v600e, one recommended therapy is vemurafenib.", "If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is vemurafenib,cobimetinib.", "If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is encorafenib,binimetinib.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is datopotamab deruxtecan.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is erlotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is osimertinib,chemotherapy.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is amivantamab,chemotherapy.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is erlotinib,ramucirumab.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is afatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is amivantamab,lazertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is gefitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is osimertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is dacomitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is afatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 20 in-frame insertions, one recommended therapy is amivantamab.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 20 in-frame insertions, one recommended therapy is sunvozertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 20 in-frame insertions, one recommended therapy is amivantamab,chemotherapy.", "If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is afatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has t790m, one recommended therapy is osimertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is afatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g776v,l841v,t798m,d821n,l755w,v842i,a710v,v697l,l755a,g776s,l869r,e717d,l866m,g815r,q709l,v794m,d808n,exon 20 in-frame insertions,v777m,l768s,v773l,l726f,l726i,t733i,l755p,l755s,i767m,d769h,d769y,v777l, one recommended therapy is zongertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is trastuzumab deruxtecan.", "If a patient with Breast Cancer cancer has e380,s463p,y537,l536,l469v,d538, one recommended therapy is elacestrant.", "If a patient with Follicular Lymphoma cancer has a692v,y646h,y646s,y646c,y646f,y646n,a682g, one recommended therapy is tazemetostat.", "If a patient with Bladder Cancer cancer has r248c,s249c,y373c,g370c, one recommended therapy is erdafitinib.", "If a patient with Acute Myeloid Leukemia cancer has r132s,r132l,r132c,r132h,r132g, one recommended therapy is ivosidenib.", "If a patient with Intrahepatic Cholangiocarcinoma cancer has r132s,r132l,r132c,r132h,r132g, one recommended therapy is ivosidenib.", "If a patient with Cholangiocarcinoma cancer has r132s,r132l,r132c,r132h,r132g, one recommended therapy is ivosidenib.", "If a patient with Myelodysplastic Syndromes cancer has r132s,r132l,r132c,r132h,r132g, one recommended therapy is ivosidenib.", "If a patient with Oligodendroglioma cancer has r132s,r132l,r132c,r132h,r132g, one recommended therapy is vorasidenib.", "If a patient with Astrocytoma cancer has r132s,r132l,r132c,r132h,r132g, one recommended therapy is vorasidenib.", "If a patient with Acute Myeloid Leukemia cancer has r132s,r132l,r132c,r132h,r132g, one recommended therapy is olutasidenib.", "If a patient with Acute Myeloid Leukemia cancer has r172k,r172m,r172s,r140l,r140g,r140w,r172w,r140q,r172g, one recommended therapy is enasidenib.", "If a patient with Oligodendroglioma cancer has r172k,r172m,r172s,r172w,r172g, one recommended therapy is vorasidenib.", "If a patient with Astrocytoma cancer has r172k,r172m,r172s,r172w,r172g, one recommended therapy is vorasidenib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is sunitinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is regorafenib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is ripretinib.", "If a patient with Mastocytosis cancer has d816, one recommended therapy is avapritinib.", "If a patient with Low-Grade Serous Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is avutometinib,defactinib.", "If a patient with Colorectal Cancer cancer has g12c, one recommended therapy is adagrasib,cetuximab.", "If a patient with Non-Small Cell Lung Cancer cancer has g12c, one recommended therapy is sotorasib.", "If a patient with Non-Small Cell Lung Cancer cancer has g12c, one recommended therapy is adagrasib.", "If a patient with Colorectal Cancer cancer has g12c, one recommended therapy is sotorasib,panitumumab.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 14 in-frame deletions,exon 14 deletion,d1010,exon 14 splice mutations, one recommended therapy is capmatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 14 in-frame deletions,exon 14 deletion,d1010,exon 14 splice mutations, one recommended therapy is tepotinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has exon 18 missense mutations,exon 18 in-frame deletions,exon 18 in-frame insertions, one recommended therapy is avapritinib.", "If a patient with Breast Cancer cancer has n345k,e545q,q546k,q546p,m1043v,m1043i,g1049r,r88q, one recommended therapy is capivasertib,fulvestrant.", "If a patient with Breast Cancer cancer has oncogenic mutations, one recommended therapy is inavolisib,palbociclib,fulvestrant.", "If a patient with Breast Cancer cancer has c420r,e542k,e545a,e545d,e545g,e545k,q546e,q546r,h1047l,h1047r,h1047y, one recommended therapy is alpelisib,fulvestrant.", "If a patient with Breast Cancer cancer has c420r,e542k,e545a,e545d,e545g,e545k,q546e,q546r,h1047l,h1047r,h1047y, one recommended therapy is capivasertib,fulvestrant.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has v299l,f317l,f317i,f317c,t315a,f317v, one recommended therapy is nilotinib.", "If a patient with Chronic Myelogenous Leukemia cancer has v299l,f317l,f317i,f317c,t315a,f317v, one recommended therapy is nilotinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has y253h,f359v,f359c,f317i,f317c,f359i,t315a,f317v,e255k,e255v, one recommended therapy is bosutinib.", "If a patient with Chronic Myelogenous Leukemia cancer has y253h,f359v,f359c,f317i,f317c,f359i,t315a,f317v,e255k,e255v, one recommended therapy is bosutinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has y253h,f359v,f359c,f359i,e255k,e255v, one recommended therapy is dasatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has y253h,f359v,f359c,f359i,e255k,e255v, one recommended therapy is dasatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l1196m, one recommended therapy is lorlatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is lorlatinib.", "If a patient with Pilocytic Astrocytoma cancer has v600e, one recommended therapy is selumetinib.", "If a patient with Hairy Cell Leukemia cancer has v600e, one recommended therapy is vemurafenib.", "If a patient with Langerhans Cell Histiocytosis cancer has v600, one recommended therapy is vemurafenib.", "If a patient with Diffuse Glioma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.", "If a patient with Encapsulated Glioma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.", "If a patient with Pleomorphic Xanthoastrocytoma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.", "If a patient with Pilocytic Astrocytoma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.", "If a patient with Ganglioglioma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.", "If a patient with Langerhans Cell Histiocytosis cancer has v600, one recommended therapy is dabrafenib.", "If a patient with Colorectal Cancer cancer has v600e, one recommended therapy is encorafenib,panitumumab.", "If a patient with Erdheim-Chester Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.", "If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.", "If a patient with Rosai-Dorfman Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.", "If a patient with Erdheim-Chester Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.", "If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.", "If a patient with Rosai-Dorfman Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.", "If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is amivantamab,chemotherapy.", "If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is erlotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is osimertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is gefitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is dacomitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has a763_y764insfqea, one recommended therapy is erlotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is amivantamab,chemotherapy.", "If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is dacomitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is osimertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is erlotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is gefitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is dacomitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is erlotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is osimertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is gefitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is amivantamab,chemotherapy.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is ado-trastuzumab emtansine.", "If a patient with Cervical Cancer cancer has oncogenic mutations, one recommended therapy is neratinib.", "If a patient with Breast Cancer cancer has oncogenic mutations, one recommended therapy is neratinib,trastuzumab,fulvestrant.", "If a patient with Breast Cancer cancer has v422del, one recommended therapy is elacestrant.", "If a patient with Bladder Cancer cancer has oncogenic mutations, one recommended therapy is erdafitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is erdafitinib.", "If a patient with Chondrosarcoma cancer has oncogenic mutations, one recommended therapy is ivosidenib.", "If a patient with Oligodendroglioma cancer has oncogenic mutations, one recommended therapy is ivosidenib.", "If a patient with Astrocytoma cancer has oncogenic mutations, one recommended therapy is ivosidenib.", "If a patient with Melanoma cancer has v654a,k642e,v560d,v560g,v560del,y553_k558del,p577del,l576p,w557g,l576del,w557r,d579del,v559a, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has c809g,a829p,d816,d820,n822,y823d, one recommended therapy is sorafenib.", "If a patient with Erdheim-Chester Disease cancer has oncogenic mutations, one recommended therapy is cobimetinib.", "If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations, one recommended therapy is cobimetinib.", "If a patient with Rosai-Dorfman Disease cancer has oncogenic mutations, one recommended therapy is cobimetinib.", "If a patient with Erdheim-Chester Disease cancer has oncogenic mutations, one recommended therapy is trametinib.", "If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations, one recommended therapy is trametinib.", "If a patient with Rosai-Dorfman Disease cancer has oncogenic mutations, one recommended therapy is trametinib.", "If a patient with Hepatobiliary Cancer cancer has g12c, one recommended therapy is adagrasib.", "If a patient with Pancreatic Adenocarcinoma cancer has g12c, one recommended therapy is adagrasib.", "If a patient with Small Bowel Cancer cancer has g12c, one recommended therapy is adagrasib.", "If a patient with Colorectal Cancer cancer has g12c, one recommended therapy is adagrasib,panitumumab.", "If a patient with Ampullary Cancer cancer has g12c, one recommended therapy is sotorasib.", "If a patient with Ampullary Cancer cancer has g12c, one recommended therapy is adagrasib.", "If a patient with Pancreatic Adenocarcinoma cancer has g12c, one recommended therapy is sotorasib.", "If a patient with Small Bowel Cancer cancer has g12c, one recommended therapy is sotorasib.", "If a patient with Colorectal Cancer cancer has g12c, one recommended therapy is sotorasib,cetuximab.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 14 in-frame deletions,exon 14 deletion,d1010,exon 14 splice mutations, one recommended therapy is crizotinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has d842v, one recommended therapy is dasatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is sunitinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is regorafenib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is ripretinib.", "If a patient with Breast Cancer cancer has oncogenic mutations (excluding c420r, e542k, e545a, e545d, e545g, e545k, q546e, q546r, h1047l, h1047r and h1047y), one recommended therapy is alpelisib,fulvestrant.", "If a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is dostarlimab.", "If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is dostarlimab.", "If a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is ipilimumab,nivolumab.", "If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is ipilimumab,nivolumab.", "If a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is nivolumab.", "If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is nivolumab.", "If a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is pembrolizumab.", "If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is pembrolizumab.", "If a patient with Colorectal Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is dostarlimab.", "If a patient with Small Bowel Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is dostarlimab.", "If a patient with Colorectal Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is ipilimumab,nivolumab.", "If a patient with Small Bowel Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is ipilimumab,nivolumab.", "If a patient with Colorectal Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is nivolumab.", "If a patient with Small Bowel Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is nivolumab.", "If a patient with Colorectal Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is pembrolizumab.", "If a patient with Small Bowel Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is pembrolizumab.", "If a patient with Ovarian Cancer cancer has e17k, one recommended therapy is capivasertib.", "If a patient with Endometrial Cancer cancer has e17k, one recommended therapy is capivasertib.", "If a patient with Neuroblastoma cancer has f1245v, one recommended therapy is lorlatinib.", "If a patient with Neuroblastoma cancer has f1174l, one recommended therapy is lorlatinib.", "If a patient with Neuroblastoma cancer has r1275q, one recommended therapy is lorlatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is nvl-655.", "If a patient with Neuroblastoma cancer has r1275l, one recommended therapy is lorlatinib.", "If a patient with Neuroblastoma cancer has f1174c, one recommended therapy is lorlatinib.", "If a patient with Neuroblastoma cancer has f1245y, one recommended therapy is lorlatinib.", "If a patient with Histiocytosis cancer has v600, one recommended therapy is vemurafenib.", "If a patient with Histiocytosis cancer has v600, one recommended therapy is dabrafenib.", "If a patient with Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.", "If a patient with Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.", "If a patient with Melanoma cancer has k601, one recommended therapy is trametinib.", "If a patient with Melanoma cancer has l597, one recommended therapy is trametinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l861q,exon 19 in-frame deletions,exon 19 in-frame insertions,l858r,s768i,g719, one recommended therapy is patritumab deruxtecan.", "If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is amivantamab,lazertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 20 in-frame insertions, one recommended therapy is poziotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has exon 20 in-frame insertions, one recommended therapy is zipalertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l718q, one recommended therapy is afatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is amivantamab,lazertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has e709_t710delinsd, one recommended therapy is afatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g724s, one recommended therapy is afatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l718v, one recommended therapy is afatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is amivantamab,lazertinib.", "If a patient with Breast Cancer cancer has oncogenic mutations, one recommended therapy is neratinib.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is neratinib.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is zongertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is sevabertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is trastuzumab,pertuzumab,docetaxel.", "If a patient with Breast Cancer cancer has oncogenic mutations (excluding fusions), one recommended therapy is fulvestrant.", "If a patient with Glioma cancer has r132, one recommended therapy is ivosidenib.", "If a patient with Histiocytosis cancer has oncogenic mutations, one recommended therapy is cobimetinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g12a,g12d,g12r,g12s,g12v, one recommended therapy is daraxonrasib.", "If a patient with Pancreatic Adenocarcinoma cancer has g12a,g12d,g12r,g12s,g12v, one recommended therapy is daraxonrasib.", "If a patient with Histiocytosis cancer has oncogenic mutations, one recommended therapy is trametinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g12d, one recommended therapy is asp3082.", "If a patient with Pancreatic Adenocarcinoma cancer has g12d, one recommended therapy is asp3082.", "If a patient with Tubular Adenoma of the Colon cancer has g12c, one recommended therapy is adagrasib.", "If a patient with Esophagogastric Cancer cancer has g12c, one recommended therapy is adagrasib.", "If a patient with Anal Cancer cancer has g12c, one recommended therapy is adagrasib.", "If a patient with Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach cancer has g12c, one recommended therapy is adagrasib.", "If a patient with Non-Small Cell Lung Cancer cancer has h1094y, one recommended therapy is elzovantinib.", "If a patient with Non-Small Cell Lung Cancer cancer has y1003, one recommended therapy is tepotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has y1003, one recommended therapy is capmatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has y1003, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has f1200i, one recommended therapy is elzovantinib.", "If a patient with Renal Cell Carcinoma cancer has l2427q,l2209v, one recommended therapy is temsirolimus.", "If a patient with Bladder Cancer cancer has e2014k,e2419k, one recommended therapy is everolimus.", "If a patient with Renal Cell Carcinoma cancer has q2223k, one recommended therapy is everolimus.", "If a patient with All Solid Tumors cancer has g595r, one recommended therapy is selitrectinib.", "If a patient with All Solid Tumors cancer has g623r, one recommended therapy is selitrectinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g2032r, one recommended therapy is taletrectinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l2086f, one recommended therapy is cabozantinib.", "If a patient with All Solid Tumors cancer has y220c, one recommended therapy is rezatapopt.", "If a patient with All Solid Tumors cancer has g469a,g469r,g469v,g464, one recommended therapy is plixorafenib.", "If a patient with All Solid Tumors cancer has k601, one recommended therapy is plixorafenib.", "If a patient with All Solid Tumors cancer has l597, one recommended therapy is plixorafenib.", "If a patient with Non-Small Cell Lung Cancer cancer has l747p, one recommended therapy is afatinib.", "If a patient with Glioma cancer has r108k,t263p,a289v, one recommended therapy is lapatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has a763_y764insfqea, one recommended therapy is afatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has d761y, one recommended therapy is osimertinib.", "If a patient with Hepatobiliary Cancer cancer has oncogenic mutations, one recommended therapy is neratinib.", "If a patient with Biliary Tract cancer has oncogenic mutations, one recommended therapy is neratinib.", "If a patient with Hepatobiliary Cancer cancer has oncogenic mutations, one recommended therapy is trastuzumab deruxtecan.", "If a patient with Biliary Tract cancer has oncogenic mutations, one recommended therapy is trastuzumab deruxtecan.", "If a patient with Hepatobiliary Cancer cancer has oncogenic mutations, one recommended therapy is pertuzumab,trastuzumab.", "If a patient with Biliary Tract cancer has oncogenic mutations, one recommended therapy is pertuzumab,trastuzumab.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is erdafitinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is fexagratinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has c809g,a829p,d816,d820,n822,y823d, one recommended therapy is nilotinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has c809g,a829p,d816,d820,n822,y823d, one recommended therapy is pazopanib.", "If a patient with All Solid Tumors cancer has g12a,g12d,g12r,g12s,g12v, one recommended therapy is daraxonrasib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is trametinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is cobimetinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is binimetinib.", "If a patient with All Solid Tumors cancer has g12d, one recommended therapy is mrtx-1133.", "If a patient with All Solid Tumors cancer has g12d, one recommended therapy is asp3082.", "If a patient with Non-Small Cell Lung Cancer cancer has h1106d,r1170q,n1100s,m1250t,v1092i, one recommended therapy is elzovantinib.", "If a patient with Non-Small Cell Lung Cancer cancer has h1106d,r1170q,n1100s,m1250t,v1092i, one recommended therapy is capmatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has h1106d,r1170q,n1100s,m1250t,v1092i, one recommended therapy is tepotinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is everolimus.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is temsirolimus.", "If a patient with All Solid Tumors cancer has g595r, one recommended therapy is zurletrectinib.", "If a patient with All Solid Tumors cancer has g623r, one recommended therapy is zurletrectinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is rly-2608.", "If a patient with Breast Cancer cancer has oncogenic mutations, one recommended therapy is rly-2608,fulvestrant.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has t315i, one recommended therapy is imatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is imatinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has t315i, one recommended therapy is dasatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is dasatinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has t315i, one recommended therapy is nilotinib.", "If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is nilotinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has t315i, one recommended therapy is bosutinib.", "If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is bosutinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has v299l,f317l,g250e, one recommended therapy is bosutinib.", "If a patient with Chronic Myelogenous Leukemia cancer has v299l,f317l,g250e, one recommended therapy is bosutinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has v299l,f317l,f317i,f317c,t315a,f317v, one recommended therapy is dasatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has v299l,f317l,f317i,f317c,t315a,f317v, one recommended therapy is dasatinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has v299l,y253h,f359c,f317i,f317c,f359i,t315a,f317v,e255k,e255v,f317l,f359v,g250e, one recommended therapy is imatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has v299l,y253h,f359c,f317i,f317c,f359i,t315a,f317v,e255k,e255v,f317l,f359v,g250e, one recommended therapy is imatinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has y253h,f359v,g250e,f359c,f359i,e255k,e255v, one recommended therapy is nilotinib.", "If a patient with Chronic Myelogenous Leukemia cancer has y253h,f359v,g250e,f359c,f359i,e255k,e255v, one recommended therapy is nilotinib.", "If a patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cancer has c481s, one recommended therapy is ibrutinib.", "If a patient with Non-Small Cell Lung Cancer cancer has t790m, one recommended therapy is erlotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has t790m, one recommended therapy is gefitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has t790m, one recommended therapy is afatinib.", "If a patient with Colorectal Cancer cancer has oncogenic mutations, one recommended therapy is cetuximab.", "If a patient with Colorectal Cancer cancer has oncogenic mutations, one recommended therapy is panitumumab.", "If a patient with Colorectal Cancer cancer has oncogenic mutations, one recommended therapy is tucatinib,trastuzumab.", "If a patient with All Solid Tumors cancer has g595r, one recommended therapy is larotrectinib.", "If a patient with All Solid Tumors cancer has g623r, one recommended therapy is larotrectinib.", "If a patient with All Solid Tumors cancer has g696a, one recommended therapy is larotrectinib.", "If a patient with All Solid Tumors cancer has f617l, one recommended therapy is larotrectinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has d842v, one recommended therapy is imatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g1269a, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l1196m, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has c1156y, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has i1171n, one recommended therapy is alectinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is alectinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is ceritinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is brigatinib.", "If a patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cancer has t474s, one recommended therapy is ibrutinib.", "If a patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cancer has t316a, one recommended therapy is ibrutinib.", "If a patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cancer has c481f, one recommended therapy is ibrutinib.", "If a patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cancer has c481r, one recommended therapy is ibrutinib.", "If a patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cancer has c481y, one recommended therapy is ibrutinib.", "If a patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cancer has t474i, one recommended therapy is ibrutinib.", "If a patient with Non-Small Cell Lung Cancer cancer has c797g, one recommended therapy is osimertinib.", "If a patient with Colorectal Cancer cancer has g465r, one recommended therapy is cetuximab.", "If a patient with Colorectal Cancer cancer has g465r, one recommended therapy is panitumumab.", "If a patient with Colorectal Cancer cancer has g465e, one recommended therapy is cetuximab.", "If a patient with Colorectal Cancer cancer has g465e, one recommended therapy is panitumumab.", "If a patient with Non-Small Cell Lung Cancer cancer has c797s, one recommended therapy is osimertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l792f, one recommended therapy is osimertinib.", "If a patient with Colorectal Cancer cancer has v441d, one recommended therapy is cetuximab.", "If a patient with Colorectal Cancer cancer has v441d, one recommended therapy is panitumumab.", "If a patient with Colorectal Cancer cancer has v441g, one recommended therapy is cetuximab.", "If a patient with Colorectal Cancer cancer has v441g, one recommended therapy is panitumumab.", "If a patient with Non-Small Cell Lung Cancer cancer has l718q, one recommended therapy is osimertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g724s, one recommended therapy is osimertinib.", "If a patient with Non-Small Cell Lung Cancer cancer has d761y, one recommended therapy is gefitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l718v, one recommended therapy is osimertinib.", "If a patient with Colorectal Cancer cancer has s464l, one recommended therapy is cetuximab.", "If a patient with Colorectal Cancer cancer has s464l, one recommended therapy is panitumumab.", "If a patient with Colorectal Cancer cancer has s492r, one recommended therapy is cetuximab.", "If a patient with Colorectal Cancer cancer has s492r, one recommended therapy is panitumumab.", "If a patient with Non-Small Cell Lung Cancer cancer has l792h, one recommended therapy is osimertinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has d820, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has d820, one recommended therapy is sunitinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has y823d, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has y823d, one recommended therapy is sunitinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has n822, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has n822, one recommended therapy is sunitinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has c809g, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has c809g, one recommended therapy is sunitinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has v654a, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has d816, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has d816, one recommended therapy is sunitinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has t670i, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has a829p, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has a829p, one recommended therapy is sunitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has d1228n, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has d1228n, one recommended therapy is cabozantinib.", "If a patient with Non-Small Cell Lung Cancer cancer has d1228n, one recommended therapy is capmatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has y1230h, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has y1230h, one recommended therapy is capmatinib.", "If a patient with All Solid Tumors cancer has g595r, one recommended therapy is entrectinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g2032r, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has g2032r, one recommended therapy is lorlatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l2086f, one recommended therapy is lorlatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has l2086f, one recommended therapy is repotrectinib.", "If a patient with Anaplastic Large-Cell Lymphoma ALK Positive cancer has fusions, one recommended therapy is crizotinib.", "If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is ceritinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is ensartinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is alectinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is brigatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is lorlatinib.", "If a patient with Low-Grade Glioma, NOS cancer has fusions, one recommended therapy is tovorafenib.", "If a patient with Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 cancer has fusions, one recommended therapy is pemigatinib.", "If a patient with Cholangiocarcinoma cancer has fusions, one recommended therapy is pemigatinib.", "If a patient with Cholangiocarcinoma cancer has fusions, one recommended therapy is futibatinib.", "If a patient with Acute Leukemias of Ambiguous Lineage cancer has fusions, one recommended therapy is revumenib.", "If a patient with Acute Myeloid Leukemia cancer has fusions, one recommended therapy is revumenib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has fusions, one recommended therapy is revumenib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is zenocutuzumab.", "If a patient with Pancreatic Adenocarcinoma cancer has fusions, one recommended therapy is zenocutuzumab.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is larotrectinib.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is repotrectinib.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is entrectinib.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is larotrectinib.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is entrectinib.", "If a patient with Myelodysplastic/Myeloproliferative Neoplasms cancer has fusions, one recommended therapy is imatinib.", "If a patient with Myelodysplastic/Myeloproliferative Neoplasms cancer has fusions, one recommended therapy is imatinib.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is selpercatinib.", "If a patient with Medullary Thyroid Cancer cancer has oncogenic mutations, one recommended therapy is selpercatinib.", "If a patient with Thyroid Cancer cancer has fusions, one recommended therapy is selpercatinib.", "If a patient with Thyroid Cancer cancer has fusions, one recommended therapy is pralsetinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is selpercatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is pralsetinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is taletrectinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is entrectinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is repotrectinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has bcr-abl1 fusion, one recommended therapy is imatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is imatinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has bcr-abl1 fusion, one recommended therapy is dasatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is nilotinib.", "If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is dasatinib.", "If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is bosutinib.", "If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is asciminib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has bcr-abl1 fusion, one recommended therapy is ponatinib.", "If a patient with Dermatofibrosarcoma Protuberans cancer has col1a1-pdgfb fusion, one recommended therapy is imatinib.", "If a patient with APL with PML-RARA cancer has pml-rara fusion, one recommended therapy is tretinoin.", "If a patient with APL with PML-RARA cancer has pml-rara fusion, one recommended therapy is arsenic trioxide.", "If a patient with APL with PML-RARA cancer has pml-rara fusion, one recommended therapy is tretinoin,arsenic trioxide.", "If a patient with APL with PML-RARA cancer has pml-rara fusion, one recommended therapy is arsenic trioxide.", "If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is ceritinib.", "If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is brigatinib.", "If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is lorlatinib.", "If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is alectinib.", "If a patient with Erdheim-Chester Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.", "If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.", "If a patient with Rosai-Dorfman Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.", "If a patient with Pilocytic Astrocytoma cancer has fusions, one recommended therapy is selumetinib.", "If a patient with Erdheim-Chester Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.", "If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.", "If a patient with Rosai-Dorfman Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.", "If a patient with Pancreatic Cancer cancer has fusions, one recommended therapy is erdafitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is erdafitinib.", "If a patient with Bladder Cancer cancer has oncogenic mutations, one recommended therapy is erdafitinib.", "If a patient with Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 cancer has fusions, one recommended therapy is ruxolitinib.", "If a patient with Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 cancer has fusions, one recommended therapy is fedratinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is imatinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is sunitinib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is regorafenib.", "If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is ripretinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is cabozantinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is ceritinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is lorlatinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has bcr-abl1 fusion, one recommended therapy is bosutinib.", "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has bcr-abl1 fusion, one recommended therapy is nilotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is nvl-655.", "If a patient with Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.", "If a patient with Melanoma cancer has fusions, one recommended therapy is trametinib.", "If a patient with Ovarian Cancer cancer has fusions, one recommended therapy is trametinib.", "If a patient with Melanoma cancer has fusions, one recommended therapy is cobimetinib.", "If a patient with Ovarian Cancer cancer has fusions, one recommended therapy is cobimetinib.", "If a patient with Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.", "If a patient with Cholangiocarcinoma cancer has oncogenic mutations, one recommended therapy is lirafugratinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is seribantumab.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is zenocutuzumab.", "If a patient with Medullary Thyroid Cancer cancer has oncogenic mutations, one recommended therapy is pralsetinib.", "If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is vandetanib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is erdafitinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is fexagratinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is erdafitinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is lirafugratinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is fexagratinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is erdafitinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is fexagratinib.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is crizotinib.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is zurletrectinib.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is zurletrectinib.", "If a patient with All Solid Tumors cancer has fusions, one recommended therapy is zurletrectinib.", "If a patient with Ewing Sarcoma cancer has ewsr1-fli1 fusion, one recommended therapy is tk216.", "If a patient with Ewing Sarcoma of Soft Tissue cancer has ewsr1-fli1 fusion, one recommended therapy is tk216.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Ovary/Fallopian Tube cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Peritoneal Serous Carcinoma cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is olaparib,bevacizumab.", "If a patient with Ovary/Fallopian Tube cancer has oncogenic mutations, one recommended therapy is olaparib,bevacizumab.", "If a patient with Peritoneal Serous Carcinoma cancer has oncogenic mutations, one recommended therapy is olaparib,bevacizumab.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib,abiraterone,prednisone.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib,abiraterone,prednisone.", "If a patient with Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Ovary/Fallopian Tube cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Peritoneal Serous Carcinoma cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is niraparib.", "If a patient with Ovary/Fallopian Tube cancer has oncogenic mutations, one recommended therapy is niraparib.", "If a patient with Peritoneal Serous Carcinoma cancer has oncogenic mutations, one recommended therapy is niraparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is niraparib,abiraterone acetate,prednisone.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is niraparib,abiraterone acetate,prednisone.", "If a patient with Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Ovary/Fallopian Tube cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Peritoneal Serous Carcinoma cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is olaparib,bevacizumab.", "If a patient with Ovary/Fallopian Tube cancer has oncogenic mutations, one recommended therapy is olaparib,bevacizumab.", "If a patient with Peritoneal Serous Carcinoma cancer has oncogenic mutations, one recommended therapy is olaparib,bevacizumab.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib,abiraterone,prednisone.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib,abiraterone,prednisone.", "If a patient with Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Ovary/Fallopian Tube cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Peritoneal Serous Carcinoma cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is niraparib,abiraterone acetate,prednisone.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is niraparib,abiraterone acetate,prednisone.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is trastuzumab.", "If a patient with Esophagogastric Adenocarcinoma cancer has amplification, one recommended therapy is trastuzumab,chemotherapy.", "If a patient with Esophagogastric Adenocarcinoma cancer has amplification, one recommended therapy is trastuzumab deruxtecan.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is trastuzumab,chemotherapy.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is ado-trastuzumab emtansine.", "If a patient with Esophagogastric Adenocarcinoma cancer has amplification, one recommended therapy is pembrolizumab,trastuzumab,chemotherapy.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is lapatinib,capecitabine.", "If a patient with Colorectal Cancer cancer has amplification, one recommended therapy is tucatinib,trastuzumab.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is lapatinib,letrozole.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is trastuzumab,pertuzumab,chemotherapy.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is neratinib.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is neratinib,capecitabine.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is trastuzumab,tucatinib,capecitabine.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is trastuzumab deruxtecan.", "If a patient with Breast Cancer cancer has amplification, one recommended therapy is margetuximab,chemotherapy.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Neurofibroma cancer has oncogenic mutations, one recommended therapy is mirdametinib.", "If a patient with Neurofibroma cancer has oncogenic mutations, one recommended therapy is selumetinib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Breast Cancer cancer has oncogenic mutations, one recommended therapy is capivasertib,fulvestrant.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.", "If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Epithelioid Sarcoma cancer has deletion, one recommended therapy is tazemetostat.", "If a patient with Encapsulated Glioma cancer has oncogenic mutations, one recommended therapy is everolimus.", "If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Acinar Cell Carcinoma of the Pancreas cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Uterine Sarcoma cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Acinar Cell Carcinoma of the Pancreas cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Uterine Sarcoma cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Uterine Sarcoma cancer has oncogenic mutations, one recommended therapy is niraparib.", "If a patient with Salivary Gland Cancer cancer has amplification, one recommended therapy is trastuzumab.", "If a patient with Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma cancer has amplification, one recommended therapy is trastuzumab,carboplatin-taxol regimen.", "If a patient with Colorectal Cancer cancer has amplification, one recommended therapy is trastuzumab,pertuzumab.", "If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is trastuzumab,pertuzumab.", "If a patient with Biliary Tract cancer has amplification, one recommended therapy is trastuzumab,pertuzumab.", "If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is tucatinib,trastuzumab.", "If a patient with Biliary Tract cancer has amplification, one recommended therapy is tucatinib,trastuzumab.", "If a patient with Colorectal Cancer cancer has amplification, one recommended therapy is lapatinib,trastuzumab.", "If a patient with Salivary Gland Cancer cancer has amplification, one recommended therapy is trastuzumab,docetaxel.", "If a patient with Salivary Gland Cancer cancer has amplification, one recommended therapy is ado-trastuzumab emtansine.", "If a patient with Colorectal Cancer cancer has amplification, one recommended therapy is trastuzumab deruxtecan.", "If a patient with Salivary Gland Cancer cancer has amplification, one recommended therapy is trastuzumab deruxtecan.", "If a patient with Salivary Gland Cancer cancer has amplification, one recommended therapy is trastuzumab,pertuzumab.", "If a patient with Follicular Lymphoma cancer has oncogenic mutations (excluding y646s, y646h, y646c, y646f, y646n, a682g and a692v), one recommended therapy is tazemetostat.", "If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is crizotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is capmatinib.", "If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is tepotinib.", "If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Acinar Cell Carcinoma of the Pancreas cancer has oncogenic mutations, one recommended therapy is rucaparib.", "If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Acinar Cell Carcinoma of the Pancreas cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Breast Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib.", "If a patient with Breast Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Acinar Cell Carcinoma of the Pancreas cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Breast Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib.", "If a patient with Breast Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.", "If a patient with Ovarian Cancer cancer has amplification, one recommended therapy is lunresertib,camonsertib.", "If a patient with Endometrial Cancer cancer has amplification, one recommended therapy is lunresertib,camonsertib.", "If a patient with Esophagogastric Cancer cancer has amplification, one recommended therapy is cetuximab.", "If a patient with Esophagogastric Cancer cancer has amplification, one recommended therapy is cetuximab,chemotherapy.", "If a patient with Esophagogastric Cancer cancer has amplification, one recommended therapy is panitumumab.", "If a patient with Esophagogastric Cancer cancer has amplification, one recommended therapy is panitumumab,chemotherapy.", "If a patient with All Solid Tumors cancer has amplification, one recommended therapy is trastuzumab deruxtecan.", "If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is zanidatamab.", "If a patient with Biliary Tract cancer has amplification, one recommended therapy is zanidatamab.", "If a patient with Bladder Cancer cancer has oncogenic mutations, one recommended therapy is cisplatin.", "If a patient with Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is lunresertib,camonsertib.", "If a patient with Endometrial Cancer cancer has oncogenic mutations, one recommended therapy is lunresertib,camonsertib.", "If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is brigimadlin.", "If a patient with Biliary Tract cancer has amplification, one recommended therapy is brigimadlin.", "If a patient with Intimal Sarcoma cancer has amplification, one recommended therapy is milademetan.", "If a patient with Dedifferentiated Liposarcoma cancer has amplification, one recommended therapy is brigimadlin.", "If a patient with Well-Differentiated Liposarcoma cancer has amplification, one recommended therapy is brigimadlin.", "If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is brigimadlin,ezabenlimab.", "If a patient with Biliary Tract cancer has amplification, one recommended therapy is brigimadlin,ezabenlimab.", "If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is telisotuzumab vedotin.", "If a patient with All Solid Tumors cancer has deletion, one recommended therapy is amg 193.", "If a patient with All Solid Tumors cancer has deletion, one recommended therapy is mrtx1719.", "If a patient with Acute Myeloid Leukemia cancer has oncogenic mutations, one recommended therapy is revumenib.", "If a patient with Ovarian Cancer cancer has oncogenic mutations, one recommended therapy is lunresertib,camonsertib.", "If a patient with Endometrial Cancer cancer has oncogenic mutations, one recommended therapy is lunresertib,camonsertib.", "If a patient with Esophageal Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is prt3789.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is prt3789.", "If a patient with Perivascular Epithelioid Cell Tumor cancer has oncogenic mutations, one recommended therapy is abi-009.", "If a patient with Uterine Perivascular Epithelioid Cell Tumor cancer has oncogenic mutations, one recommended therapy is abi-009.", "If a patient with All Solid Tumors cancer has amplification, one recommended therapy is lunresertib.", "If a patient with All Solid Tumors cancer has amplification, one recommended therapy is lunresertib,camonsertib.", "If a patient with All Solid Tumors cancer has amplification, one recommended therapy is blu-222.", "If a patient with Dedifferentiated Liposarcoma cancer has amplification, one recommended therapy is palbociclib.", "If a patient with Well-Differentiated Liposarcoma cancer has amplification, one recommended therapy is palbociclib.", "If a patient with Dedifferentiated Liposarcoma cancer has amplification, one recommended therapy is abemaciclib.", "If a patient with Well-Differentiated Liposarcoma cancer has amplification, one recommended therapy is abemaciclib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is palbociclib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is ribociclib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is abemaciclib.", "If a patient with Glioma cancer has amplification, one recommended therapy is lapatinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is lunresertib,camonsertib.", "If a patient with All Solid Tumors cancer has amplification, one recommended therapy is lirafugratinib.", "If a patient with Bladder Cancer cancer has oncogenic mutations, one recommended therapy is tazemetostat.", "If a patient with All Solid Tumors cancer has amplification, one recommended therapy is brigimadlin.", "If a patient with Dedifferentiated Liposarcoma cancer has amplification, one recommended therapy is milademetan.", "If a patient with Well-Differentiated Liposarcoma cancer has amplification, one recommended therapy is milademetan.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is trametinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is cobimetinib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is lunresertib,camonsertib.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is gsk2636771.", "If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is azd8186.", "If a patient with All Liquid Tumors cancer has oncogenic mutations, one recommended therapy is tazemetostat.", "If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is bemcentinib,pembrolizumab.", "If a patient with Chronic Myelomonocytic Leukemia cancer has oncogenic mutations, one recommended therapy is ceralasertib.", "If a patient with Myelodysplastic Syndromes cancer has oncogenic mutations, one recommended therapy is ceralasertib.", "If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is erlotinib.", "If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is gefitinib.", "If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is osimertinib."]